Keeping up with the science: Innovation in the health and care system post Brexit

Article

Innovation in health – new treatments, technologies and processes – can help drive improvements in healthcare and ultimately health outcomes. We are on the cusp of a new wave of innovation driven by robotics, big data and therapeutic breakthroughs such as cell and gene therapy.

However, the history of innovation in the UK shows that the health and care system is often slow to adopt new technologies. The government has tried to address the causes of this problem, most recently through the Accelerated Access Review (AAR) and Life Sciences (Industrial) Strategy.

Although these initiatives offer a number of sensible policy suggestions, the reality is that they will fail to deliver on their potential without a Brexit deal that prioritises health and care; a new long-term funding settlement for health and care; and a clear plan for system reform in the NHS.

Related items

  1. Doctor with patient for consultation, medical advice or procedure at clinic

    Taken to heart: Inequalities in heart disease in Scotland

    More than 7.6 million people across the UK live with cardiovascular disease (CVD), around twice as many as live with Alzheimer’s disease and cancer combined. 
  2. A beautiful sunset in the Scottish highlands with renewable energy wind turbines far into the horizon

    Skills passports: An essential part of a fair transition

    This month, government will publish its Clean Energy Workforce Strategy. This plan covers two aims. First, filling the growing demand for skills in clean energy industries is essential to keep on track to reach the government’s clean power…
  3. The Bank of England is watched over by a statue of the Duke of Wellington seated on his horse

    Fixing the leak: How to end the £22 billion annual taxpayer losses at the Bank of England

    The Bank of England increased its interest rates over recent years, aimed at reducing inflation. But this has also had an unintended effect on the Bank of England’s massive government bond buying – ‘quantitative easing’ – programme.